Rodri’s Back Surgery Clouds Man City’s Season Before It Even Starts
Real Madrid loanee scores first career hat-trick in stunning Lyon debut
Man City have a problem. Before a ball has been kicked in the 2025-26 season, their most important midfielder is on the operating table with no firm return date in sight.
Rodri underwent back surgery this week, and while the club have described it as a 'short period of rehabilitation', that kind of vague language never inspires confidence. There's no timeline, no target game, and no indication of what 'short' actually means in practice.
For anyone building bets around Man City this summer and into the new campaign, this is the story that matters most.
The Player They Simply Cannot Replace
We've said it before and we'll say it again: no team in European football is more dependent on a single midfielder than Man City are on Rodri. Pep Guardiola has built his entire midfield structure around the Spaniard's ability to control tempo, break up play and protect the back four.
When Rodri went down with an ACL injury in September 2024, Man City fell apart. They won just one of their next eight Premier League games. The title race was effectively over before Christmas.
This is a man who was named player of the tournament at the World Cup after guiding Spain to glory. He's the best defensive midfielder in the world. Losing him again, even for a few weeks, shifts the balance of power at the top of the league.
How This Changes the Betting Picture
Man City are due to face Arsenal in the Community Shield on 16 August and then open their Premier League season against Bournemouth on 23 August. Neither of those games will feature Rodri, and that matters.
For title odds, we think Man City's price should be treated with real caution until we know two things: when Rodri is back, and whether he returns to full fitness. Arsenal and Liverpool will be watching this closely, and any bookmaker pricing Man City as clear favourites for the title right now is asking you to take on risk that isn't fully priced in.
Our view is simple. Back Man City for individual matches once Rodri returns and looks sharp. Don't back them for anything long-term until that's confirmed. If you're building an accumulator around early-season Man City results, factor in that they'll be playing without their most influential player in their opening fixtures.
The Real Madrid Subplot
There's another layer to this that makes the situation messier. Rodri has been heavily linked with a move to Real Madrid all summer. He has one year left on his contract and won't sign an extension until City meet his demands, which by all accounts are significant.
Back surgery at this stage of a transfer saga is either a complication that kills the move or something that Madrid were already aware of. Either way, it creates uncertainty around whether Rodri will even be a Man City player beyond January, let alone next summer.
If there's any chance he moves mid-season, then Man City's odds for a Premier League title become very difficult to back at current prices. A squad that was already stretched in midfield without him would be in serious trouble.
Gvardiol Signs, But That's Not the Story
The club also confirmed that Josko Gvardiol has signed a new five-year deal, keeping him at the Etihad until 2031. That's good business and locks down one of their best defensive assets, but it doesn't change the conversation around Rodri.
Gvardiol's extension is a positive footnote. The Rodri situation is the headline.
Our Take on Man City's Odds
We're not fading Man City completely. They have the squad depth, the manager and the infrastructure to cope in the short term. Enzo Maresca has been around this system long enough to paper over the gaps.
What we won't do is back Man City at tight title odds until Rodri is back and clearly fit. The evidence from last season is too strong to ignore. Without him, they're still a top-four side. With him, they're genuine title favourites.
Wait for clarity before committing real money to Man City futures. The value will still be there once we know more, and patience here is the smartest play.